<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02296073</url>
  </required_header>
  <id_info>
    <org_study_id>PICUDEX2014</org_study_id>
    <nct_id>NCT02296073</nct_id>
  </id_info>
  <brief_title>The Efficacy and the Safety of Dexmedetomidine Sedation on the Pediatric Intensive Unit(PICU) Patients.</brief_title>
  <official_title>The Efficacy and the Safety of Dexmedetomidine Sedation on the PICU Patients-A Randomized, Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Anhui Provincial Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Anhui Provincial Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To observe the efficacy and safety of dexmedetomidine sedation on the patients admitted to
      the pediatric intensive care unit after surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of time at target sedation score</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>assess the sedation level every 2 min using Ramsay score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the number of patients requiring the sedation remedy</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>the number of patients requiring the sedation remedy during the mechanical ventilation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the dosage of midazolam that need for the sedation remedy</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>the dosage of midazolam that need for sedation remedy during the mechanical ventilation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change of blood pressure</measure>
    <time_frame>up to 24 hours.</time_frame>
    <description>the change of blood pressure at 1 min、10 min、20 min、30 min、1 hours、2 hours、3 hours、4 hours、5 hours、6 hours、12 hours、18 hours、24 hours after the sedation drug used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of heart rate</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>the change of heart rate at 1 min、10 min、20 min、30 min、1 hours、2 hours、3 hours、4 hours、5 hours、6 hours、12 hours、18 hours、24 hours after the sedation drug used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of respiratory rate</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>the change of respiratory rate at 1 min、10 min、20 min、30 min、1 hours、2 hours、3 hours、4 hours、5 hours、6 hours、12 hours、18 hours、24 hours after the sedation drug used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of blood oxygen saturation</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>the change of blood oxygen saturation at 1 min、10 min、20 min、30 min、1 hours、2 hours、3 hours、4 hours、5 hours、6 hours、12 hours、18 hours、24 hours after the sedation drug used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>extubation time</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>time from beginning of study drug used to extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of hepatic function</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>change of blood ALT、AST level at baseline and 24 hours after the sedation drug used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of renal function</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>change of blood Cr、BUN level at baseline and 24 hours after the sedation drug used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the dosage of sedation and analgesia drug</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>the total dosage of sedation and analgesia drug during the sedation and analgesia period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the number of patients requiring fentanyl analgesia in and after 6 hours from study drug used</measure>
    <time_frame>up to 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the dosage of fentanyl in and after 6 hours from study drug used</measure>
    <time_frame>up to 24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Failed Conscious Sedation During Procedure</condition>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>midazolam 3～5μg/kg•min for maintenance of sedation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine 0.5μg/kg intravenous bump for 15 min，then 0.2～1.4μg/(kg.h) for maintenance of sedation；</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine 0.25μg/kg intravenous bump for 15 min，then 0.2～1.4μg/(kg.h) for maintenance of sedation；</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomiding3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine 0.2～1.4μg/(kg.h) for maintenance of sedation；</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>midazolam 3～5μg/kg•min for maintenance of sedation.</description>
    <arm_group_label>Midazolam</arm_group_label>
    <other_name>Liyuexi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine 0.5μg/kg intravenous bump for 15 min，then 0.2～1.4μg/(kg.h) for maintenance of sedation；</description>
    <arm_group_label>Dexmedetomidine1</arm_group_label>
    <other_name>Yisi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine 0.25μg/kg intravenous bump for 15 min，then 0.2～1.4μg/(kg.h) for maintenance of sedation；</description>
    <arm_group_label>Dexmedetomidine2</arm_group_label>
    <other_name>Yisi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine 0.2～1.4μg/(kg.h) for maintenance of sedation；</description>
    <arm_group_label>Dexmedetomiding3</arm_group_label>
    <other_name>Yisi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Fentanyl 0.5～4 μg/(kg.h) for maintenance of analgesia</description>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_label>Dexmedetomidine1</arm_group_label>
    <arm_group_label>Dexmedetomidine2</arm_group_label>
    <arm_group_label>Dexmedetomiding3</arm_group_label>
    <other_name>Fentai</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>assessment</intervention_name>
    <description>Ramsay score for sedation assessment, Facial expression, leg movement, activity, cry, and consolability score (FLACC) for analgesia assessment.</description>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_label>Dexmedetomidine1</arm_group_label>
    <arm_group_label>Dexmedetomidine2</arm_group_label>
    <arm_group_label>Dexmedetomiding3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. written informed consent；

          2. pediatric patients admitted to intensive care unit after general anesthesia;

          3. expected mechanical ventilation time &gt;6 hours; （4）1 months to 16 years old; -

        Exclusion Criteria:

          1. congenital heart disease, arrhythmias and heart failure;

          2. Alanine transaminase（ALT） and (or) Aspartate aminotransferase（AST） level is more than
             twice the upper limit of normal;

          3. Creatinine and (or) Blood urea nitrogen（BUN） is more than the upper limit of normal;

          4. central nervous system disease;

          5. spinal analgesia or muscle relaxants is used during PICU;

          6. the drug that affects the nerve conduction is used in one month;

          7. allergy to the test drug or having other contraindications;

          8. participated in other studies 30 days prior to admission of PICU; -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2014</study_first_submitted>
  <study_first_submitted_qc>November 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2014</study_first_posted>
  <last_update_submitted>November 19, 2014</last_update_submitted>
  <last_update_submitted_qc>November 19, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Anhui Provincial Children's Hospital</investigator_affiliation>
    <investigator_full_name>Yuanyuan Xu</investigator_full_name>
    <investigator_title>Anesthesia Department</investigator_title>
  </responsible_party>
  <keyword>Pediatric intensive care unit</keyword>
  <keyword>Sedation</keyword>
  <keyword>Dexmedetomidine</keyword>
  <keyword>mechanical ventilation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

